Background & Summary {#Sec1}
====================

Tissues comprise individual cells of diverse types along with supportive membranes and structures as well as blood and lymphatic vessels. The identities, properties and spatial distributions of cells that make up tissues are still not fully known: classical histology provides excellent spatial resolution, but it typically lacks molecular details. As a result, the impact of intrinsic factors such as lineage and extrinsic factors such as the microenvironment on tissue biology in health and disease requires molecular profiling of single cells within the broader context of organized tissue architecture. Such deep spatial and molecular phenotyping is especially pertinent to the study of cancer resection tissues. These samples are routinely acquired prior to, on, and after a therapeutic intervention, providing opportunities to characterize the interplay between malignant tumor cells and surrounding immune cell populations and how those relationships are influenced over time by treatments. Understanding these relationships may elucidate biomarker signatures that predict response to therapy^[@CR1],[@CR2]^ and is particularly relevant in the case of immunotherapeutics. Many available immunotherapies, including those targeting cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), programmed cell death-1 receptor (PD-1), and programmed cell death-1 ligand (PD-L1), influence interactions between tumor and immune cells to inhibit immune checkpoints and activate the immune system's surveillance of tumor cells^[@CR3]--[@CR7]^. However, even in tumor types that are highly responsive to such therapies, many patients do not benefit, and many types of tumors remain broadly refractory to these agents. A deeper understanding of immune cell states, location, interactions, and architecture ("immunophenotypes") promises to provide new prognostic and predictive information for cancer research and treatment.

With recent advances in multiplexed imaging technologies^[@CR8]^, multiple epitopes can be detected within a tissue section and the spatial distributions and interactions of cell populations precisely mapped. One such method is tissue-based cyclic immunofluorescence (t-CyCIF)^[@CR9]^ which yields high-plex images at subcellular resolution and has been used to characterize immune populations in several tumor types^[@CR10]--[@CR13]^. In t-CyCIF, a high-plex image is constructed from a series of 4 to 6 color images, which are then registered and superimposed. The images provide information on the amount of epitope that is expressed as well as the location of the epitope within the tissue. By segmenting the images to demarcate single cells or subcellular compartments, we can then use epitope expression levels to discriminate immune, tumor, and stromal cell types and compute their numbers and distributions within tumors and surrounding normal tissue.

The quality of the antibody reagents largely dictates the reliability of data that is generated by antibody-based imaging methods such as multiplexed ion beam imaging (MIBI)^[@CR14]^, imaging mass cytometry (IMC)^[@CR15]^, co-detection by indexing (CODEX)^[@CR16]^, DNA exchange imaging (DEI)^[@CR17]^, MultiOmyx (MxIF)^[@CR18]^, imaging cycler microscopy (ICM)^[@CR19]--[@CR21]^, multiplexed IHC^[@CR22]^, NanoString Digital Spatial Profiling (DSP)^[@CR23]^, and t-CyCIF itself. We have recently published detailed methods for validating antibodies and assembling panels of antibodies for multiplexed tissue techniques^[@CR24]^. That work highlights a variety of complementary approaches to qualify antibodies using information at the level of pixels, cells, and tissues and yielded a 16-plex antibody panel capable of detecting lymphocytes, macrophages, and immune checkpoint regulators for use in 'immune profiling' tissue samples. Using t-CyCIF, we qualified antibodies in reactive (non-neoplastic) tonsil tissue (TONSIL-1), which has a highly stereotyped arrangement of diverse immune cell types, and then demonstrated the panel's utility in characterizing common and rare immune populations in three lung cancer tissue specimens: a lung adenocarcinoma that had metastasized to a lymph node (LUNG-1-LN), a lung squamous cell carcinoma that had metastasized to the brain (LUNG-2-BR), and a primary lung squamous cell carcinoma (LUNG-3-PR). We also provide t-CyCIF imaging data from eight FFPE sections used to validate antibodies; in these samples, antibodies were applied in different permutations and order, making the data useful for examining relationships between antigenicity, fluorescence signal, and cycle number.

In this data descriptor, we share the images from our recent work^[@CR24]^. The dataset includes immunofluorescence images from formalin fixed paraffin embedded (FFPE) tissue sections mounted onto glass slides. In each section, there are between \~61,800 to \~483,000 individual cells with fluorescence intensity and spatial information provided for 27 antibodies that were acquired in a multiplexed fashion. These antibodies include the highly validated 16-plex immune panel as well as antibodies against several additional markers of interest such as markers of tumor cell lineage and cell proliferation. We also include quantitative, single-cell measurements of 60+ features including fluorescence intensity measurements for each target epitope/protein, cellular morphology measurements such as area, eccentricity, and solidity, and spatial information such as the centroid position of each cell and its nearest neighbors.

The resulting single-cell data can be analyzed using qualitative and quantitative approaches both in the context of the original spatial arrangement of the tissue and as sets of derived feature vectors, one for each cell. Spatial views enable the analysis of geographic patterns and interactions between different cells types, such as the immune microenvironment surrounding tumor tissue. Such data can be used to develop new methods for visualizing large complex images and to develop and refine data analysis approaches such as image segmentation, intensity gating (to discriminate 'positive' and 'negative' cell populations), and spatial clustering. As multiple research centers begin to assemble high-dimensional and multi-parametric atlases of human cancers and pre-cancers^[@CR25]^, there is an increasing need for cross-center validation of analysis methodologies. Publicly available datasets such as ours will provide a freely accessible resource for such efforts.

Methods {#Sec2}
=======

Tissue samples {#Sec3}
--------------

Five formalin-fixed paraffin-embedded (FFPE) human tissue samples were retrieved from the archives of the Department of Pathology at Brigham and Women's Hospital with IRB approval as part of a discarded tissue protocol. The diagnoses were confirmed by a board-certified pathologist (S.S.) (Table [1](#Tab1){ref-type="table"}). Sections were cut from FFPE blocks at a thickness of 5 µm and mounted onto Superfrost Plus microscope slides prior to use.Table 1Sample Information.Sample CodeData SetTissue TypeClinical ClassificationTONSIL-11Human tonsil tissueNormal tonsilLUNG-1-LN1Human lung carcinoma tissueLung adenocarcinoma metastasis to lymph nodeLUNG-2-BR1Human lung carcinoma tissueLung squamous cell carcinoma metastasis to brainLUNG-3-PR1Human lung carcinoma tissuePrimary lung squamous cell carcinomaTONSIL-2.12Human tonsil tissueReactive tonsilTONSIL-2.22Human tonsil tissueReactive tonsilTONSIL-2.32Human tonsil tissueReactive tonsilTONSIL-2.42Human tonsil tissueReactive tonsilTONSIL-2.52Human tonsil tissueReactive tonsilTONSIL-2.62Human tonsil tissueReactive tonsilTONSIL-2.72Human tonsil tissueReactive tonsilTONSIL-2.82Human tonsil tissueReactive tonsil

Datasets {#Sec4}
--------

Data from tissue samples was acquired in two batches. The first batch (DATASET-1) contains data from LUNG-1-LN, LUNG-2-BR, LUNG-3-PR, and TONSIL-1. The second batch (DATASET-2) contains data from eight sections of TONSIL-2. Data associated with each of these sections are labeled TONSIL-2.1, TONSIL-2.2, etc. in the data records. Note that in the sample coding system, the number after the dash denotes patient sample and the number after the decimal point denotes block section.

Tissue-based cyclic immunofluorescence {#Sec5}
--------------------------------------

Each section of tissue was imaged with a panel of 26--28 antibodies using t-CyCIF as previously described^[@CR9]^. This method consists of iterative cycles of antibody incubation, imaging, and fluorophore inactivation (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Overview of data generation. (**a**) Multiplexed, immunofluorescence images were acquired using the tissue-based cyclic immunofluorescence (t-CyCIF) method and (**b**) processed with a series of algorithms and toolboxes including BaSiC, ASHLAR, ilastik, and histoCAT to obtain single-cell features.

### Slide preparation {#Sec6}

An automated program on the Leica Bond RX (Leica Biosystems) was used to prepare slides for t-CyCIF. The slides were treated as follows: baked at 60 °C for 30 min, dewaxed at 72 °C with Bond Dewax Solution (Cat. AR9222, Leica Biosystems), and treated with Epitope Retrieval 1 (ER1) Solution at 100 °C for 20 min for antigen retrieval. Odyssey Blocking Buffer (Cat. 927--40150, LI-COR) was applied to the slides at room temperature (RT) for 30 min and then incubated with three secondary antibodies at RT for 60 min, followed by Hoechst 33342 (Cat. H3570, Life Technologies) solution (2 ug/ml) at RT for 30 min.

### Blocking {#Sec7}

After slide preparation, non-specific, reactive epitopes were blocked by incubating slides overnight at 4 °C in the dark with fluorescently conjugated secondary antibodies raised against the host species of the unconjugated, primary antibodies used in the first cycle of t-CyCIF.

### Antibody staining {#Sec8}

Slides were initially imaged to measure nonspecific binding from secondary antibodies, photobleached, and then imaged again to measure tissue autofluorescence. In the first cycle of antibody incubation, the slides were incubated overnight with primary antibodies from different species and then with corresponding secondary antibodies for two hours at RT in the dark. Slides were then washed with 1X PBS, stained with Hoechst solution, and then imaged. This process was repeated for 11--12 cycles using antibodies directly conjugated to fluorophores. All antibodies used in this study are listed in Online-only Table [1](#Tab3){ref-type="table"} with an assigned unique identifier. Antibodies and imaging parameters used for each cycle of imaging for all samples in DATASET-1 are detailed in Online-only Table [2](#Tab4){ref-type="table"} and for all samples in DATASET-2 in Online-only Table [3](#Tab5){ref-type="table"}.

### Mounting and de-coverslipping {#Sec9}

Prior to each cycle of imaging, slides were wet-mounted using 200 µl of 10% glycerol in PBS and 24 × 50 mm glass cover slips (Cat \# 48393-081, VWR). Following imaging, the slides were de-coverslipped by placing the slides vertically in a slide rack completely submerged in a container of 1X PBS for 15 minutes and slowly pulling the slides back up, allowing the glass coverslip to remain in the PBS.

### Image acquisition {#Sec10}

Images from each cycle of t-CyCIF were acquired using the RareCyte CyteFinder Slide Scanning Fluorescence Microscope. The four following filter sets were used: 1) The 'DAPI channel' for imaging Hoechst with a peak excitation of 390 nm and half-width of 18 nm and a peak emission of 435 nm and half-width of 48 nm, 2) the '488 channel' with a 475-nm/28-nm excitation filter and a 525-nm/48-nm emission filter, 3) the '555 channel' with a 542-nm/27-nm excitation filter and a 597-nm/45-nm emission filter, and 4) the '647 channel' with a 632-nm/22-nm excitation filter and a 679-nm/34-nm emission filter. Each tissue section was imaged twice, a large region with a 10X/0.3 NA objective and a smaller region with a 40X/0.6NA objective. The 10X images have a field of view of 1.6 × 1.4 mm and a nominal resolution of 1.06 µm. The 40X images have a field of view of 0.42 × 0.35 mm and a nominal resolution of 0.53 µm. For both sets of images, a 5% overlap was collected between fields of view to facilitate image stitching. In DATASET-2, the first cycle of antibodies was imaged twice, once with a high exposure time and once with a low exposure time.

### Photobleaching {#Sec11}

Following slide preparation using the Leica Bond RX and subsequent to each cycle of imaging, fluorophores were inactivated by submerging slides in a solution of 4.5% H~2~O~2~ and 20 mM NaOH in 1X PBS and incubating them under a light emitting diode (LED) for 2 hours at RT.

Image processing {#Sec12}
----------------

### Background and shading correction {#Sec13}

The BaSiC algorithm^[@CR26]^ plugin for ImageJ was used to computationally derive flat-field and dark-field profiles from the original image for each cycle. The flat-field is used to correct for irregular illumination of the sample, and the dark-field is used to correct for camera sensor offset and internal noise. Lambda values of 0.1 and 0.01 were used for flat-field and dark-field, respectively. For each cycle, the raw image was subtracted by the dark-field profile and divided by the flat-field profile to correct the shading on each individual image field.

### Stitching and registration {#Sec14}

ASHLAR (version v1.6.0) was used to stitch the fields from the first imaging cycle into a mosaic and to co-register the fields from successive cycles of imaging. Ashlar stitches fields together by calculating the phase correlation between neighboring images to correct for local state positioning error and applying a statistical model of microscope stage behavior to correct for large-scale error. It then uses a similar phase correlation approach to register fields from successive cycles to the first cycle of stitched images. The output is an OME-TIFF file that contains a seamless multi-channel mosaic depicting the entire sample across all image cycles.

### Segmentation {#Sec15}

The OME-TIFF output from ASHLAR was used to segment single cells in the images using the ilastik software program^[@CR27]^ and MATLAB (version 2018a). The OME-TIFF was cropped into 6000 × 6000 pixel regions to increase processing speed. From each cropped region, \~20 random 250 × 250 pixel regions were selected and used as training data in the ilastik program to generate a probability of each pixel in the cropped region belonging to three classes: nuclear area, cytoplasmic area, or area not occupied by a cell (background). During the labeling process, the user was presented with the DAPI channel only. The user labeled pixels with DAPI as nuclei, pixels on the border or a few pixels away from DAPI signal as cytoplasm, and pixels distant from DAPI signal as background. While labeling by the user was performed using only one DAPI channel, all 44 channels from the stitched and registered images were used by ilastik to train the pixel classification algorithm. Color/intensity features including gaussian smoothing, edge features including the Laplacian of gaussian, gaussian of gradient magnitude, and difference of gaussians, and texture features including structure tensor eigenvalues and hessian of gaussian eigenvalues with a σ~0~ = 0.30, σ~1~ = 0.70, σ~2~ = 1.00, σ~3~ = 1.60, σ~4~ = 3.50, and σ~5~ = 5.03 were used to train the pixel classification in ilastik. The ilastik software generated three probability masks, one for each of the three classes. For example, the cytoplasmic probability mask was a TIFF image, with each pixel containing a value between 0 to 65535 where larger values indicate higher probability of that pixel belonging to the cytoplasmic class. The probability masks along with morphological manipulations were used in MATLAB to perform a watershed transformation and identify objects, or cell nuclei. The output from MATLAB was a nuclear segmentation mask for each cropped region. Please see below for a description of the qualitative and quantitative approaches we used for the technical validation and assessment of the segmentation.

### Single-cell feature extraction {#Sec16}

The histology topography cytometry analysis toolbox (histoCAT)^[@CR28]^ was used to extract features of the cells segmented in each image. Single cell features included fluorescence intensity measurements of each antibody, morphological features such as cell area and circularity, as well as spatial features such as the centroid position of the cell. Moreover, cells in spatial proximity to one another were identified and indexed to enable neighborhood analysis and cell phenotype interactions. The output was a data table for each cropped region. For each sample, the data tables from all the cropped regions were concatenated into a master image level data table with each cell assigned a global unique identifier and centroid position. A complete list and description of each feature in the master data tables is provided in Online-only Table [4](#Tab6){ref-type="table"}.

Data Records {#Sec17}
============

We have made all the data for this manuscript available in the Synapse repository hosted by Sage Bionetworks 10.7303/syn17865732 ^[@CR29]^. We organized the data as described in Fig. [2](#Fig2){ref-type="fig"}. For each tissue sample, we share image data acquired at two magnifications. For each 40X magnification in DATASET-1, we share:i.raw rcpnl files,ii.illumination profiles generated by the BaSiC algorithm,iii.an OME-TIFF file output from the ASHLAR algorithm,iv.individual TIFF images for each marker,v.probability masks for segmentation from ilastik software,vi.labeled nuclear segmentation mask, andvii.data table of 60+ features extracted for each cell.Fig. 2Database structure. All shared data are stored in the SYNAPSE repository. 10.7303/syn17865732

The "rcpnl" folder contains the raw image files in an rcpnl file format generated by the RareCyte CyteFinder for each cycle of imaging. The "illumprofs" folder contains TIFF files for the dark-field profile and the flat-field profile for each cycle of imaging. Each TIFF file in this folder is a stack of four TIFF images corresponding to the four wavelengths imaged every cycle. The "ometiff" folder contains one OME-TIFF file that is a stitched, registered mosaic of all channels across all cycles of imaging. The OME-TIFF file has a pyramidal structure that contains mosaics at multiple resolutions. The "singletiff" folder contains a single TIFF mosaic for each marker at the highest resolution. This folder separates the OME-TIFF into separate channels to facilitate opening in software that is incompatible with the OME-TIFF format. The "segmentation" folder contains subfolders with intermediate data outputs from the segmentation process. The "cropped" subfolder contains 6000 × 6000 pixel regions from the OME-TIFF file. The "training" subfolder contains 250 × 250 pixel regions used as training data for segmentation. The "ilastikprob" subfolder contains a TIFF image for the probability of each pixel in the cropped regions belonging to each class used in ilastik training. The "ilastikseg" folder contains a TIFF image of the nuclear segmentation mask. This folder also contains an TIFF image stack with the segmentation mask and the DAPI fluorescence image from the first cycle of imaging for easy comparison of the accuracy of the probability mask. The "features" folder contains a csv data table for each cropped region with 60+ feature measurements for each cell as well as a master data table with data from each cropped region combined. Note that the X and Y coordinates for the centroid of the cell in the master table reflects the global position of the cell in the entire piece of tissue imaged/stitched image.

We provide all scripts used in data generation. A description of the scripts and supporting documents is provided in Online-only Table [5](#Tab7){ref-type="table"}.

Additionally, a subset of the imaging data can be found and viewed on cycif.org ([https://www.cycif.org/featured-paper/du-lin-rashid-2019/figures/](https://www.cycif.org/featured-paper/du-and-lin-2019/figures/)). In this interactive image browser, we indicate several distinct regions of interest in the tonsil and lung cancer images and provide descriptive narrations about a subset of the combinations of immune markers expressed in these samples.

Technical Validation {#Sec18}
====================

Staining quality {#Sec19}
----------------

We performed a detailed validation of the panel of antibodies used to generate the datasets described in our prior work^[@CR24]^. One or more trained pathologists visually reviewed the staining patterns for each antibody to assess specificity to cell type, appropriate localization within the cell (e.g. nucleus v. cytoplasm v. membrane), co-staining with other markers, and localization to the expected geographic regions within the tissue. For example, the cytokeratin antibody, known to detect intermediate filament proteins in epithelial cells, was expressed in striated patterns surrounding the nuclei of cells morphologically consistent with epithelial origin, whereas the FOXP3 antibody, targeting a transcription factor in T cells, was concentrated in the nuclear area of small, round cells morphologically consistent with lymphocytes (Fig. [3a](#Fig3){ref-type="fig"}). Antibodies detecting cell lineage markers such as FOXP3, which delineates a regulatory T-cell population, were further corroborated by assessing appropriate co-expression of other markers. For example, we found that FOXP3 was co-expressed with CD4, CD3D, and CD45, thereby increasing our confidence in the staining quality (Fig. [3a](#Fig3){ref-type="fig"}). As another example, CD20, a B-cell antigen, was observed to have higher levels of signal within germinal centers of tonsil tissue which are well-established B cell rich compartments within tonsil rather than the mantle region where we found an abundance of cells expressing the T-cell antigen CD3D (Fig. [3b](#Fig3){ref-type="fig"}). See our prior publication^[@CR23]^ for additional quality measurements including the comparison of t-CyCIF antibody staining to the staining observed with clinical grade antibodies that were used in immunohistochemistry (IHC) staining, pixel-by-pixel correlations of multiple antibody clones against the same target, and various high-dimensional cell clustering methods.Fig. 3Antibody staining quality. (**a**) Immunofluorescence image from LUNG-3-PR showing epithelial tumor cells marked by Keratin (white) and a regulatory T cell marked by FOXP3 (cyan), CD4 (yellow), CD3D (red), and CD45 (green) (scale bar: 25 µm; inset scale bar: 10 µm). (**b**) A region of TONSIL-1 showing CD20 (green) and CD3D (red) expression. Area inside yellow dashed circle denotes germinal center (GC), and area outside denotes the mantle (M) region (scale bar: 100 µm). (**c**) Probability density function of fluorescence signal intensity of every pixel in the germinal center (n = 1,446,450 pixels) and mantle (n = 4,369,358 pixels) for CD20 and CD3D within the region shown in (**b**). X-axis is fluorescence intensity (log2 au) and y-axis is frequency of pixels.

Cell segmentation {#Sec20}
-----------------

We evaluated the quality of segmentation of single cells within the tissue images using a two-step system. We only performed segmentation on the 40X magnification images because the lower resolution of the 10X magnification images reduced segmentation accuracy. First, we overlaid the segmentation masks over the DAPI signal to evaluate the accuracy of segmentation qualitatively (Fig. [4a](#Fig4){ref-type="fig"}); based on these data, we then adjusted and optimized the segmentation. Second, three users evaluated a random sample of 500 cells from the tonsil and each of the lung tissues to quantify the accuracy, or true positives, and rate of fusion errors (under-segmentation) and fission/splitting errors (over-segmentation) among mis-segmented cells (Fig. [4b-c](#Fig4){ref-type="fig"}, Table [2](#Tab2){ref-type="table"}). The cell segmentation of all samples had a low error rate (\~0.1) across cells of various morphologies (large tumor cells, smaller round immune cells, elongated fibroblasts, etc.). The accuracy of image segmentation can be further improved with the development of new algorithms.Fig. 4Assessment of segmentation. (**a**) Representative images of DAPI staining and corresponding segmentation mask in TONSIL-1 and LUNG-3-PR. (**b**) Examples of fusion (under-segmentation) and (**c**) fission/splitting (over-segmentation).Table 2Segmentation Accuracy.LUNG-1-LNLUNG-2-BRLUNG-3-PRTONSIL-1MeanSDMeanSDMeanSDMeanSDTrue Positive0.8720.0130.8900.0170.8990.0130.8630.012Fusion0.0860.0270.0740.0170.0530.0190.0380.020Fission0.0420.0170.0360.0030.0470.0080.0990.025

In our analysis of these images, we observed that the area covered by the nuclear mask effectively captured the signal from the nuclear compartment as well as the cytoplasmic/membranous compartment as can be observed in Fig. [3a](#Fig3){ref-type="fig"}. The presence of cytoplasmic signal in the nuclear compartment in this dataset is in part attributable to the three-dimensional nature of the five-micron thick tissue sections which we imaged. These sections capture the complex intermingling of nuclear and cytoplasmic compartments that occurs in individual cells. Thus, the signal that is ultimately projected into a two-dimensional image does not arise strictly from one cellular compartment. Moreover, the high cellular density in these tumor and tonsil tissues in combination with high intensity fluorescence signal created conditions where expanding the nuclear segmentation mask captured signal from neighboring cells. Therefore, in our single-cell analyses, we used the nuclear segmentation mask to extract signal intensity features for both nuclear and cytoplasmic markers.

Single-cell feature extraction {#Sec21}
------------------------------

To assess the integrity of the single-cell features extracted from the images, we applied an unsupervised, k-means clustering method to the data from the three lung cancer resection samples and the reactive (non-neoplastic) tonsil sample. This analysis yielded four cardinal cell types (clusters) using three lineage markers (Fig. [5a](#Fig5){ref-type="fig"}). For each sample, the cells clustered into an epithelial group marked by keratin expression, a stromal group marked by αSMA expression, and an immune group marked by CD45 expression. A fourth group was marked by low expression of all three markers. We then isolated the cells in the immune group and further clustered them using other lymphocyte markers (Fig. [5b,c](#Fig5){ref-type="fig"}). The clustering revealed similar immune cell populations to those observed by visual review of the images and as quantified previously using other computational methods^[@CR24]^. Each cluster exhibited varying degrees of tightness, or fit. The probability density function plot for each cluster in Fig. [5a,c](#Fig5){ref-type="fig"} displays the distance of each cell from the centroid of the cluster, with the y-axis denoting distance and the x-axis denoting the frequency of cells belonging to each distance bin. The range of the curve along the y-axis reflects the fit, with a smaller range denoting greater fit and a larger range denoting poorer fit. The variability of cluster fit can be explained by the intrinsic heterogeneity within different immune populations. Tighter clusters where the majority of the cells have short distances from the center represent populations with distinct and highly similar marker expression profiles. Looser clusters, with wider distance ranges and longer tails, likely contain subpopulations of immune cells that may require further stratification and investigation. While this exercise displays fundamental immune cell populations reported in the literature, we note the potential of multiplexed data and unsupervised methods to reveal novel cell populations and states. Here, using alternative segmentation, feature extraction, and computational approaches, we retained reproducible immune cell populations, giving us confidence in the robustness of this dataset.Fig. 5Heatmaps of cell populations from lung cancer and tonsil tissues using k-means clustering demonstrates distinct cell immune populations with expected patterns of biomarker expression. (**a**) Heatmap of the expression of Keratin, αSMA, and CD45 in all cells that were collected from LUNG-1-LN, LUNG-2-BR, LUNG-3-PR, and TONSIL-1 using k-means clustering. Each row is a cluster. The last column in each heat map shows the probability density function (pdf) plot showing the fit of each cell within the cluster, with the x-axis denoting the frequency of cells and y-axis denoting the Euclidean distance of the cell from the centroid of the cluster. The black vertical bars mark the immune cluster with high CD45 expression. (**b**,**c**) Heatmaps showing the expression of seven lymphocyte markers (CD45, CD3D, CD8A, CD4, CD20, PD1, FOXP3) from the cells within the CD45 high cluster from panel (a). (**b**) Each row represents protein marker expression data from a single cell or (**c**) each row represents a cluster. Note that fluorescence intensity values were log transformed and normalized between --1 to 1 as indicated by the color bar. (**d**) Galleries of immunofluorescence images of representative cells from each cluster in (**c**). (Scale bar: 5 µm).

Usage Notes {#Sec22}
===========

More information on the t-CyCIF method used to generate this data can be found at: [www.cycif.org](http://www.cycif.org) and a detailed protocol can be found in Lin *et al*.^[@CR9]^ and Du, Lin, Rashid *et al*. 2019^[@CR24]^.

A narrative of the dataset is available for interactive web-browsing here: [https://www.cycif.org/featured-paper/du-lin-rashid-2019/figures/](https://www.cycif.org/featured-paper/du-and-lin-2019/figures/).

Open data agreement: Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer by Rumana Rashid, Giorgio Gaglia, Yu-An Chen, Jia-Ren Lin, Ziming Du, Zoltan Maliga, Denis Schapiro, Clarence Yapp, Jeremy Muhlich, Artem Sokolov, Peter Sorger and Sandro Santagata is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Based on a work at 10.7303/syn17865732.

Online-only Tables {#Sec23}
==================

Online-only Table 1Antibody Unique Identifiers.IDNameVendorCatalog1CD68Cell Signaling Technology795942CD3BioLegend3004223CD11aBioLegend3012074CD15BioLegend3019105CD16BioLegend3020196CD19BioLegend3022197CD25BioLegend3026178CD28BioLegend3029549CD38BioLegend30351110CD45BioLegend30405611CD64BioLegend30501212CD80BioLegend30520713CD83BioLegend30530814CD86BioLegend30540515CD86BioLegend30541616CD123BioLegend30603517CD69BioLegend31090418CD206BioLegend32111619EpCamBioLegend32420520Her2BioLegend32441221CD1cBioLegend33150522CD305BioLegend34280223CD134BioLegend35001824CD103BioLegend35020925Ki67BioLegend35050926CD138BioLegend35230827TIM1BioLegend35390428CD25BioLegend35610429CD27BioLegend35640630CD49bBioLegend35930531CD33BioLegend36660832ABCC1BioLegend37020333IFNGBioLegend50251734CD16BD Biosiences55812235GATA3BDBiosiences 56016336pH2AXBioLegend61341237Annexin VBioLegend64091138NFATc1BioLegend64960539Beta-cateninBioLegend65870540VIMBioLegend67780741CD11aeBioscience11-0119-4142Ki67Cell Signaling Technology11882 s43CD66bThermo-Fisher12-0666-4144Ki67Cell Signaling Technology12075 S45CD133eBioscience12-1338-4146VEGFR2Cell Signaling Technology12634 S47pAurCell Signaling Technology13464 S48STINGCell Signaling Technology13647 S49IRF1Cell Signaling Technology14105 S50PD-L1Cell Signaling Technology15005 S51Beta-TubulinCell Signaling Technology2116 S52pH3Cell Signaling Technology3475 S53CD45RInvitrogen41-0452-8054CD4eBioscience41-2444-8255FoxP3eBioscience41-4777-8256KeratineBioscience41-9003-8257Her2eBioscience41-9757-8058CD11ceBioscience41-9761-8059VinculineBioscience41-9777-8060GFAPeBioscience41-9892-8061CD11cCell Signaling Technology45581 S62CD8aeBioscience50-0008-8263CD3eBioscience50-0037-4164CD20eBioscience50-0202-8065aSMAeBioscience50-9760-8266RunX3eBioscience50-9817-8067CD11beBioscience53-0196-8068CD45RBeBioscience53-9458-8069TIM3Cell Signaling Technology54669 S70EGFRCell Signaling Technology5616 S71PDL2Cell Signaling Technology82723 S72PCNACell Signaling Technology8580 S73LaminA/CCell Signaling Technology8617 S74AxlCell Signaling Technology8661 S75CD1cAbcamab15670876LAG3Abcamab18018777CD115Abcamab18331678LaminA/CAbcamab18501479g TubulinAbcamab19111480TDP43Abcamab19384281Lamin BAbcamab19410882IBA1Abcamab19503183CD14Abcamab19616984CD19Abcamab19646885FibronectinAbcamab19893386STINGAbcamab19895287HLA-AAbcamab19983788CD1aAbcamab20133789PD-1Abcamab20182590aSMAAbcamab20250991CD21Abcamab20269392CD69Abcamab20290993SQSTM1Abcamab20343094CD11bAbcamab20427195FOXO1AAbcamab20724496S100aAbcamab20736797CD3Abcamab20851498BANF1Abcamab20853499CTLA4Abcamab210254100PMLAbcamab217524101CD163Abcamab218293102PKRAbcamab219739103CD2Abcamab37212104IBA1BiossAIF1105BRD7AvivaARP39018-P050106CD45R&D SystemsFAB1430P-025107CD31R&D SystemsFAB3567P108CD4R&D SystemsFAB8165G109CD45RODakoM0742110GATA3Thermo-FisherMA1-028111IDOEMD-MilliporeMAB10009112RORyTEMD-MilliporeMABF81113CCR7InvitrogenPA5-32299114CD16Santa Cruzsc-20052 AF647115CD209Santa Cruzsc-65740116p-cJunSanta Cruzsc-822117Arl13bAntibodies Inc.75-287118CD45RODakoM0742119Hoechst 33342Cell Signaling Technology4082 S

Online-only Table 2Antibody Staining Plan for DATASET-1.channel_numbercycle_numbermarker_namefluorescence_labelwavelength_nameexcitation_wavelengthemission_wavelengthantibody_IDantibody_vendorantibody_catalogantibody_dilutionexposure_time (sec)11DAPI_1Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.121A488 backgroundFITC485525131A555 backgroundCy3555590141A647 backgroundCy5640690152DAPI_2Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.0562A488 backgroundAlexa 488FITC485525172A555 backgroundAlexa 555Cy3555590182A647 backgroundAlexa 647Cy5640690193DAPI_3Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.075103A488 backgroundAlexa 488FITC4855251113LAG3Alexa 555Cy355559076Abcamab1801871:1001123ARL13BAlexa 647Cy5640690117Antibodies Incorporated75-2871:1001134DAPI_4Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.05144KI67Alexa 488FITC48552542Cell Signaling Technology11882 s1:1001154KERATINAlexa 555Cy355559056eBioscience41-9003-801:2001164PD1Alexa 647Cy564069089Abcamab2018251:1001175DAPI_5Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.02185CD45RBAlexa 488FITC48552568eBioscience53-9458-801:1001195CD3DAlexa 555Cy355559097Abcamab2085141:1001205PDL1Alexa 647Cy564069050Cell Signaling Technology15005 S1:501216DAPI_6Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.02226CD4Alexa 488FITC485525108R&D SystemsFAB8165G1:1001236CD45Alexa 555Cy3555590106R&D SystemsFAB1430P-0251:1001246CD8AAlexa 647Cy564069062eBioscience50-0008-801:1001257DAPI_7Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.05267CD163Alexa 488FITC485525101Abcamab2182931:1001277CD68Alexa 555Cy35555901Cell Signaling Technology795941:1001287CD14Alexa 647Cy564069083Abcamab1961691:1000.75298DAPI_8Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.15308CD11BAlexa 488FITC48552567eBioscience53-0196-801:1000.75318FOXP3Alexa 555Cy355559055eBioscience41-4777-801:1001328CD21Alexa 647Cy564069091Abcamab2026931:1000.2339DAPI_9Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.05349IBA1Alexa 488FITC48552582Abcamab1950311:2500.75359ASMAAlexa 555Cy355559090Abcamab2025091:2500.2369CD20Alexa 647Cy564069064eBioscience50-0202-801:2500.23710DAPI_10Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.13810CD19Alexa 488FITC48552594Abcamab1964681:10013910GFAPAlexa 555Cy355559060eBioscience41-9892-801:1000.14010GTUBULINAlexa 647Cy564069079Abcamab1911141:10014111DAPI_11Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.0754211LAMINACAlexa 488FITC48552578Abcamab1850141:1000.54311BANF1Alexa 555Cy355559098Abcamab2085341:10014411LAMINBAlexa 647Cy564069081Abcamab1941081:1000.4

Online-only Table 3Antibody Staining Plan for DATASET-2.samplechannel_numbercycle_numbermarker_namefluorescence_labelwavelength_nameexcitation_wavelengthemission_wavelengthantibody_IDantibody_vendorantibody_cataloganitbody_dilutionexposure_time(sec)TONSIL-2.111DAPI_1Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.121A488 backgroundFITC4855250.5TONSIL-2.131A555 backgroundCy35555900.5TONSIL-2.141A647 backgroundCy56406900.5TONSIL-2.152DAPI_2Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.162A488 backgroundFITC4855250.2TONSIL-2.172A555 backgroundCy35555900.2TONSIL-2.182A647 backgroundCy56406900.2TONSIL-2.193DAPI_3Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.1103CD11cAlexa 488FITC48552561Cell Signaling Technology45581 S1:3000.5TONSIL-2.1113A555 backgroundCy35555900.5TONSIL-2.1123CD209Alexa 647Cy5640690115Santa Cruzsc-657401:1000.5TONSIL-2.1134DAPI_4Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.1144CD11cAlexa 488FITC48552561Cell Signaling Technology45581 S1:3000.2TONSIL-2.1154A555 backgroundCy35555900.2TONSIL-2.1164CD209Alexa 647Cy5640690115Santa Cruzsc-657401:1000.2TONSIL-2.1175DAPI_5Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.1185CD4Alexa 488FITC485525108R&D SystemsFAB8165G1:3000.5TONSIL-2.1195CD68Alexa 555Cy35555901Cell Signaling Technology79594 S1:10000.5TONSIL-2.1205CD20Alexa 647Cy564069064eBioscience50-0202-801:10000.5TONSIL-2.1216DAPI_6Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.1226PCNAAlexa 488FITC48552572Cell Signaling Technology8580 S1:10000.2TONSIL-2.1236CD4Alexa 555Cy355559054eBioscience41-2444-821:2000.5TONSIL-2.1246CD14Alexa 647Cy564069083Abcamab1961691:10000.2TONSIL-2.1257DAPI_7Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.1267EGFRAlexa 488FITC48552570Cell Signaling Technology5616 S1:5000.5TONSIL-2.1277CD11cAlexa 555Cy355559058eBioscience41-9761-801:3\'1:3\'1:30.5TONSIL-2.1287VIMAlexa 647Cy564069040BioLegend6778071:5000.1TONSIL-2.1298DAPI_8Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.1308IBA1Alexa 488FITC48552582Abcamab1950311:5000.5TONSIL-2.1318CD86Alexa 555Cy355559014BioLegend3054051:1000.5TONSIL-2.1328CD45Alexa 647Cy564069010BioLegend3040561:3000.5TONSIL-2.1339DAPI_9Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.1349CD11bAlexa 488FITC48552594Abcamab2042711:3000.5TONSIL-2.1359CD3DAlexa 555Cy355559097Abcamab2085141:1\'1:500.5TONSIL-2.1369CD64Alexa 647Cy564069011BioLegend3050121:1\'1:500.5TONSIL-2.13710DAPI_10Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.13810CD19Alexa 488FITC4855256BioLegend3022191:2000.5TONSIL-2.13910FoxP3Alexa 555Cy355559055eBioscience41-4777-821:1\'1:500.5TONSIL-2.14010CD134Alexa 647Cy564069023BioLegend3500181:3000.5TONSIL-2.14111DAPI_11Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.14211IFNGAlexa 488FITC48552533BioLegend5025171:1\'1:500.5TONSIL-2.14311PMLAlexa 555Cy3555590100Abcamab2175241:1\'1:500.5TONSIL-2.14411CD305Alexa 647Cy564069022BioLegend3428021:1\'1:500.5TONSIL-2.14512DAPI_12Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.14612TIm3Alexa 488FITC48552569Cell Signaling Technology54669 S1:2000.5TONSIL-2.14712KeratinAlexa 555Cy355559056eBioscience41-9003-821:10000.1TONSIL-2.14812CD8aAlexa 647Cy564069062eBioscience50-0008-821:2000.5TONSIL-2.211DAPI_1Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.221A488 backgroundFITC4855250.5TONSIL-2.231A555 backgroundCy35555900.5TONSIL-2.241A647 backgroundCy56406900.5TONSIL-2.252DAPI_2Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.262A488 backgroundFITC4855250.2TONSIL-2.272A555 backgroundCy35555900.2TONSIL-2.282A647 backgroundCy56406900.2TONSIL-2.293DAPI_3Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.2103CCR7Alexa 488FITC485525113InvitrogenPA5-322991:1000.5TONSIL-2.2113A555 backgroundCy35555900.5TONSIL-2.2123CD45ROAlexa 647Cy5640690118DakoM07421:3000.5TONSIL-2.2134DAPI_4Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.2144CCR7Alexa 488FITC485525113InvitrogenPA5-322991:1000.2TONSIL-2.2154A555 backgroundCy35555900.2TONSIL-2.2164CD45ROAlexa 647Cy56406901118DakoM07421:3000.2TONSIL-2.2175DAPI_5Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.2185CD11bAlexa 488FITC48552594Abcamab2042711:3000.5TONSIL-2.2195CD3DAlexa 555Cy355559097Abcamab2085141:1\'1:500.5TONSIL-2.2205CD16PacBlueCy564069034BD Biosiences5581221:1\'1:500.5TONSIL-2.2216DAPI_6Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.2226GATA3Alexa 488FITC48552535BD Biosiences5601631:1000.5TONSIL-2.2236EpCamAlexa 555Cy355559019BioLegend3242051:3000.5TONSIL-2.2246CD45Alexa 647Cy564069010BioLegend3040561:3000.5TONSIL-2.2257DAPI_7Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.2267CD4Alexa 488FITC485525108R&D SystemsFAB8165G1:5000.5TONSIL-2.2277FoxP3Alexa 555Cy355559055eBioscience41-4777-821:2\'1:500.5TONSIL-2.2287CD20Alexa 647Cy564069064eBioscience50-0202-801:1\'1:6\'1:700.2TONSIL-2.2298DAPI_8Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.2308CD69Alexa 488FITC48552517BioLegend3109041:1000.5TONSIL-2.2318KeratinAlexa 555Cy355559056eBioscience41-9003-821:10000.1TONSIL-2.2328CD8aAlexa 647Cy564069062eBioscience50-0008-821:2000.5TONSIL-2.2339DAPI_9Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.2349IBAAlexa 488FITC48552582Abcamab1950311:5000.5TONSIL-2.2359CD25PECy355559028BioLegend3561041:1\'1:500.5TONSIL-2.2369CD86Alexa 647Cy564069015BioLegend3054161:1\'1:500.5TONSIL-2.23710DAPI_10Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.23810PCNAAlexa 488FITC48552572Cell Signaling Technology8580 S1:10000.2TONSIL-2.23910CD45RAlexa 555Cy355559053Invitrogen41-0452-801:2000.5TONSIL-2.24010CD14Alexa 647Cy564069083Abcamab1961691:10000.5TONSIL-2.24111DAPI_11Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.24211CD15Alexa 488FITC4855254BioLegend3019101:3000.2TONSIL-2.24311CD27PECy355559029BioLegend3564061:1\'1:500.2TONSIL-2.24411PDL1Alexa 647Cy564069050Cell Signaling Technology15005 S1:3000.5TONSIL-2.24512DAPI_12Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.24612CD163Alexa 488FITC485525101Abcamab2182931:3000.5TONSIL-2.24712CD68Alexa 555Cy35555901Cell Signaling Technology79594 S1:10000.5TONSIL-2.24812HLA-AAlexa 647Cy564069087Abcamab1998371:2000.2TONSIL-2.311DAPI_1Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.321A488 backgroundFITC4855250.5TONSIL-2.331A555 backgroundCy35555900.5TONSIL-2.341A647 backgroundCy56406900.5TONSIL-2.352DAPI_2Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.362A488 backgroundFITC4855250.2TONSIL-2.372A555 backgroundCy35555900.2TONSIL-2.382A647 backgroundCy56406900.2TONSIL-2.393DAPI_3Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.3103CD115Alexa 488FITC48552577Abcamab1833161:1000.5TONSIL-2.3113A555 backgroundCy35555900.5TONSIL-2.3123CD1aAlexa 555Cy564069088Abcamab2013371:300.5TONSIL-2.3134DAPI_4Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.3144CD115Alexa 488FITC48552577Abcamab1833161:1000.2TONSIL-2.3154A555 backgroundCy35555900.2TONSIL-2.3164CD1aAlexa 647Cy564069088Abcamab2013371:300.2TONSIL-2.3175DAPI_5Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.3185PCNAAlexa 488FITC48552572Cell Signaling Technology8580 S1:10000.5TONSIL-2.3195FoxP3Alexa 555Cy355559055eBioscience41-4777-821:1\'1:500.5TONSIL-2.3205IRF1Alexa 647Cy564069049Cell Signaling Technology14105 S1:2000.5TONSIL-2.3216DAPI_6Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.3226Lamin A/CAlexa 488FITC48552573Cell Signaling Technology8617 S1:3000.5TONSIL-2.3236KeratinAlexa 555Cy355559056eBioscience41-9003-821:10000.1TONSIL-2.3246CD3Alexa 647Cy564069063eBioscience50-0037-411:3000.5TONSIL-2.3257DAPI_7Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.3267CD11bAlexa 488FITC48552594Abcamab2042711:5000.5TONSIL-2.3277VinculinAlexa 555Cy355559059eBioscience41-9777-801:5000.5TONSIL-2.3287CD14Alexa 647Cy564069083Abcamab1961691:1\'1:6\'1:700.2TONSIL-2.3298DAPI_8Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.3308CD49bAlexa 488FITC48552530BioLegend3593051:1000.5TONSIL-2.3318CD68Alexa 555Cy35555901Cell Signaling Technology79594 S1:10000.5TONSIL-2.3328IBA1Alexa 647Cy5640690104BiossAIF11:1000.5TONSIL-2.3339DAPI_9Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.3349TIM3Alexa 488FITC48552569Cell Signaling Technology54669 S1:2000.5TONSIL-2.3359CD33PECy355559031BioLegend3666081:1\'1:500.5TONSIL-2.3369CD8aAlexa 647Cy564069062eBioscience50-0008-821:2000.5TONSIL-2.33710DAPI_10Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.33810CD28Alexa 488FITC4855258BioLegend3029541:1\'1:500.5TONSIL-2.33910CD3DAlexa 555Cy355559097Abcamab2085141:1\'1:500.5TONSIL-2.34010CD45Alexa 647Cy564069010BioLegend3040561:3000.5TONSIL-2.34111DAPI_11Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.34211PKR-Alexa 488FITC485525102Abcamab2197391:1\'1:500.5TONSIL-2.34311CD83PECy355559013BioLegend3053081:1\'1:500.5TONSIL-2.34411CD206Alexa 647Cy564069018BioLegend3211161:1000.5TONSIL-2.34512DAPI_12Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.34612CD4Alexa 488FITC485525108R&D SystemsFAB8165G1:3000.5TONSIL-2.34712CTLA4PECy355559099Abcamab2102541:2000.5TONSIL-2.34812CD16APCCy564069034BD Biosiences5581221:2000.5TONSIL-2.411DAPI_1Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.421A488 backgroundFITC4855250.5TONSIL-2.431A555 backgroundCy35555900.5TONSIL-2.441A647 backgroundCy56406900.5TONSIL-2.452DAPI_2Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.462A488 backgroundFITC4855250.2TONSIL-2.472A555 backgroundCy35555900.2TONSIL-2.482A647 backgroundCy56406900.2TONSIL-2.493DAPI_3Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.4103PDL2Alexa 488FITC48552571Cell Signaling Technology82723 S1:2000.5TONSIL-2.4113A555 backgroundCy35555900.5TONSIL-2.4123p-cJunAlexa 647Cy5640690116Santa Cruzsc-8221:1000.5TONSIL-2.4134DAPI_4Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.4144PDL2Alexa 488FITC48552571Cell Signaling Technology82723 S1:2000.2TONSIL-2.4154A555 backgroundCy35555900.2TONSIL-2.4164p-cJunAlexa 647Cy5640690116Santa Cruzsc-8221:1000.2TONSIL-2.4175DAPI_5Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.4185GATA3Alexa 488FITC48552535BD Biosiences5601631:2000.5TONSIL-2.4195CD66bAlexa 555Cy355559043Invitrogen12-0666-411:3000.5TONSIL-2.4205CD14Alexa 647Cy564069083Abcamab1961691:10000.5TONSIL-2.4216DAPI_6Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.4226CD11bAlexa 488FITC48552567eBioscience53-0196-801:2000.5TONSIL-2.4236CD68Alexa 555Cy35555901Cell Signaling Technology79594 S1:10000.5TONSIL-2.4246Her2Alexa 647Cy564069020BioLegend3244121:2000.5TONSIL-2.4257DAPI_7Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.4267PCNAAlexa 488FITC48552572Cell Signaling Technology8580 S1:1\'1:6\'1:700.2TONSIL-2.4277CD133Alexa 555Cy355559045eBioscience12-1338-411:3\'1:3\'1:30.5TONSIL-2.4287CD8aAlexa 647Cy564069062eBioscience50-0008-821:3\'1:3\'1:30.5TONSIL-2.4298DAPI_8Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.4308CD4Alexa 488FITC485525108R&D SystemsFAB8165G1:3000.5TONSIL-2.4318CD31Alexa 555Cy3555590107R&D SystemsFAB3567P1:1000.5TONSIL-2.4328CD103Alexa 647Cy564069024BioLegend3502091:1000.5TONSIL-2.4339DAPI_9Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.4349CD15Alexa 488FITC4855254BioLegend3019101:1\'1:500.2TONSIL-2.4359CD80PECy355559012BioLegend3052071:1\'1:500.5TONSIL-2.4369CD20Alexa 647Cy564069064eBioscience50-0202-801:10000.2TONSIL-2.43710DAPI_10Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.43810CD11bAlexa 488FITC48552594Abcamab2042711:3000.5TONSIL-2.43910KeratinAlexa 555Cy355559056eBioscience41-9003-821:10000.1TONSIL-2.44010aSMAAlexa 647Cy564069065eBioscience50-9760-821:10000.2TONSIL-2.44111DAPI_11Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.44211TDP43Alexa 488FITC48552580Abcamab1938421:1\'1:500.5TONSIL-2.44311FOXO1AAlexa 555Cy355559095Abcamab2072441:1\'1:500.5TONSIL-2.44411CD138APCCy564069026BioLegend3523081:1\'1:500.5TONSIL-2.44512DAPI_12Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.44612IBAAlexa 488FITC48552582Abcamab1950311:5000.5TONSIL-2.44712FoxP3Alexa 555Cy355559055eBioscience41-4777-821:1\'1:500.5TONSIL-2.44812CD16Alexa 647Cy5640690114Santa Cruzsc-20052 AF6471:2000.5TONSIL-2.511DAPI_1Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.521A488 backgroundFITC4855250.5TONSIL-2.531A555 backgroundCy35555900.5TONSIL-2.541A647 backgroundCy56406900.5TONSIL-2.552DAPI_2Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.562A488 backgroundFITC4855250.2TONSIL-2.572A555 backgroundCy35555900.2TONSIL-2.582A647 backgroundCy56406900.2TONSIL-2.593DAPI_3Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.5103CD2Alexa 488FITC485525103Abcamab372121:1000.5TONSIL-2.5113A555 backgroundCy35555900.5TONSIL-2.5123GATA3Alexa 647Cy5640690110Thermo-FisherMA1-0281:1000.5TONSIL-2.5134DAPI_4Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.5144CD2Alexa 488FITC485525103Abcamab372121:1000.2TONSIL-2.5154A555 backgroundCy35555900.2TONSIL-2.5164GATA3Alexa 647Cy5640690110Thermo-FisherMA1-0281:1000.2TONSIL-2.5175DAPI_5Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.5185IBAAlexa 488FITC48552582Abcamab1950311:5000.5TONSIL-2.5195KeratinAlexa 555Cy355559056eBioscience41-9003-821:10000.5TONSIL-2.5205PDL1Alexa 647Cy564069050Cell Signaling Technology15005 S1:3000.5TONSIL-2.5216DAPI_6Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.5226CD11aAlexa 488FITC48552541eBioscience11-0119-411:2000.5TONSIL-2.5236CD3DAlexa 555Cy355559097Abcamab2085141:1\'1:500.5TONSIL-2.5246PD1Alexa 647Cy564069089abcamab2018251:2000.5TONSIL-2.5257DAPI_7Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.5267GATA3Alexa 488FITC48552535BD Biosiences5601631:1\'1:6\'1:70.5TONSIL-2.5277CD68Alexa 555Cy35555901Cell Signaling Technology79594 S1:1\'1:6\'1:70.5TONSIL-2.5287Beta-cateninAlexa 647Cy564069039BioLegend6587051:5000.5TONSIL-2.5298DAPI_8Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.5308PCNAAlexa 488FITC48552572Cell Signaling Technology8580 S1:10000.2TONSIL-2.5318TIM1Alexa 555Cy355559027BioLegend3539041:1000.5TONSIL-2.5328CD20Alexa 647Cy564069064eBioscience50-0202-801:10000.2TONSIL-2.5339DAPI_9Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.5349CD4Alexa 488FITC485525108R&D SystemsFAB8165G1:3000.5TONSIL-2.5359aSMAAlexa 555Cy355559090Abcamab2025091:10000.1TONSIL-2.5369CD45Alexa 647Cy564069010BioLegend3040561:3000.5TONSIL-2.53710DAPI_10Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.53810CD19Alexa 488FITC48552584Abcamab1964681:2000.5TONSIL-2.53910pH2AXAlexa 555Cy355559036BioLegend6134121:3000.2TONSIL-2.54010RunX3Alexa 647Cy564069066eBioscience50-9817-801:2000.5TONSIL-2.54111DAPI_11Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.54211CD163Alexa 488FITC485525101Abcamab2182931:3000.5TONSIL-2.54311CD66bAlexa 555Cy355559043Thermo-Fisher12-0666-411:1000.5TONSIL-2.54411Ki67Alexa 647Cy564069025BioLegend3505091:2000.5TONSIL-2.54512DAPI_12Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.54612LaminA/CAlexa 488FITC48552573Cell Signaling Technology8617 S1:3000.5TONSIL-2.54712NFATc1Alexa 555Cy355559038BioLegend6496051:2000.5TONSIL-2.54812CD14Alexa 647Cy564069083Abcamab1961691:10000.5TONSIL-2.611DAPI_1Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.621A488 backgroundFITC4855250.5TONSIL-2.631A555 backgroundCy35555900.5TONSIL-2.641A647 backgroundCy56406900.5TONSIL-2.652DAPI_2Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.662A488 backgroundFITC4855250.2TONSIL-2.672A555 backgroundCy35555900.2TONSIL-2.682A647 backgroundCy56406900.2TONSIL-2.693DAPI_3Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.6103AxlAlexa 488FITC48552574Cell Signaling Technology8661 S1:3000.5TONSIL-2.6113A555 backgroundCy35555900.5TONSIL-2.6123IDOAlexa 647Cy5640690111EMD-MilliporeMAB100091:1000.5TONSIL-2.6134DAPI_4Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.6144AxlAlexa 488FITC48552574Cell Signaling Technology8661 S1:3000.2TONSIL-2.6154A555 backgroundCy35555900.2TONSIL-2.6164IDOAlexa 647Cy5640690111EMD-MilliporeMAB100091:1000.2TONSIL-2.6175DAPI_5Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.6185TIM3Alexa 488FITC48552569Cell Signaling Technology54669 S1:2000.5TONSIL-2.6195Her2Alexa 555Cy355559057eBioscience41-9757-801:3000.5TONSIL-2.6205CD8aAlexa 647Cy564069062eBioscience50-0008-821:2000.5TONSIL-2.6216DAPI_6Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.6226CD123Alexa 488FITC48552516BioLegend3060351:2000.5TONSIL-2.6236FoxP3Alexa 555Cy355559055eBioscience41-4777-821:1\'1:500.5TONSIL-2.6246CD20Alexa 647Cy564069064eBioscience50-0202-801:10000.2TONSIL-2.6257DAPI_7Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.6267CD163Alexa 488FITC485525101Abcamab2182931:5000.5TONSIL-2.6277NFATc1Alexa 555Cy355559038BioLegend6496051:3\'1:3\'1:30.5TONSIL-2.6287ABCC1Alexa 647Cy564069032BioLegend3702031:5000.5TONSIL-2.6298DAPI_8Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.6308CD11bAlexa 488FITC48552594Abcamab2042711:3000.5TONSIL-2.6318CD3DAlexa 555Cy355559097Abcamab2085141:1\'1:500.5TONSIL-2.6328IBA1Alexa 647Cy5640690104BiossAIF11:1000.5TONSIL-2.6339DAPI_9Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.6349CD11bAlexa 488FITC48552567eBioscience53-0196-801:2000.5TONSIL-2.6359CD68Alexa 555Cy35555901Cell Signaling Technology79594 S1:10000.5TONSIL-2.6369CD206Alexa 647Cy564069018BioLegend3211161:1\'1:500.5TONSIL-2.63710DAPI_10Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.63810IBAAlexa 488FITC48552582Abcamab1950311:5000.5TONSIL-2.63910pH3Alexa 555Cy355559052Cell Signaling Technology3475 S1:10000.1TONSIL-2.64010Ki67Alexa 647Cy564069025BioLegend3505091:10000.5TONSIL-2.64111DAPI_11Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.64211GATA3Alexa 488FITC48552535BD Biosiences5601631:1000.5TONSIL-2.64311VEGFR2PECy355559046Cell Signaling Technology12634 S1:1\'1:500.2TONSIL-2.64411IRF1Alexa 647Cy564069049Cell Signaling Technology14105 S1:2000.5TONSIL-2.64512DAPI_12Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.64612PCNAAlexa 488FITC48552572Cell Signaling Technology8580 S1:10000.2TONSIL-2.64712CD11cAlexa 555Cy355559058eBioscience41-9761-801:2000.5TONSIL-2.64812CD45Alexa 647Cy564069010BioLegend3040561:3000.5TONSIL-2.711DAPI_1Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.721A488 backgroundFITC4855250.5TONSIL-2.731A555 backgroundCy35555900.5TONSIL-2.741A647 backgroundCy56406900.5TONSIL-2.752DAPI_2Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.762A488 backgroundFITC4855250.2TONSIL-2.772A555 backgroundCy35555900.2TONSIL-2.782A647 backgroundCy56406900.2TONSIL-2.793DAPI_3Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.7103STINGAlexa 488FITC48552548Cell Signaling Technology13647 S1:1000.5TONSIL-2.7113A555 backgroundCy35555900.5TONSIL-2.7123CD1cAlexa 647Cy564069075Abcamab1567081:2000.5TONSIL-2.7134DAPI_4Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.7144STINGAlexa 488FITC48552548Cell Signaling Technology13647 S1:1000.2TONSIL-2.7154A555 backgroundCy35555900.2TONSIL-2.7164CD1cAlexa 647Cy564069075Abcamab1567081:2000.2TONSIL-2.7175DAPI_5Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.7185CD11bAlexa 488FITC48552567eBioscience53-0196-801:3000.5TONSIL-2.7195CD45RAlexa 555Cy355559053invitrogen41-0452-801:3000.5TONSIL-2.7205CD25Alexa 647Cy56406907BioLegend3026171:1\'1:500.5TONSIL-2.7216DAPI_6Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.7226CD163Alexa 488FITC485525101Abcamab2182931:3000.5TONSIL-2.7236CD1cAlexa 555Cy355559021BioLegend3315051:2000.5TONSIL-2.7246CD8aAlexa 647Cy564069062eBioscience50-0008-821:2000.5TONSIL-2.7257DAPI_7Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.7267IBAAlexa 488FITC48552582Abcamab1950311:8\'1:3\'1:30.5TONSIL-2.7277KeratinAlexa 555Cy355559056eBioscience41-9003-821:1\'1:6\'1:700.1TONSIL-2.7287CD45Alexa 647Cy564069010BioLegend3040561:5000.5TONSIL-2.7298DAPI_8Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.7308BRD7Alexa 488FITC485525105AvivaARP39018-P0501:1000.5TONSIL-2.7318Beta-TubulinAlexa 555Cy355559051Cell Signaling Technology2116 S1:3000.5TONSIL-2.7328CD14Alexa 647Cy564069083Abcamab1961691:10000.5TONSIL-2.7339DAPI_9Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.7349CD16Alexa 488FITC4855255BioLegend3020191:1\'1:500.5TONSIL-2.7359FoxP3Alexa 555Cy355559055eBioscience41-4777-821:1\'1:500.5TONSIL-2.7369CD134Alexa 647Cy564069023BioLegend3500181:1\'1:500.5TONSIL-2.73710DAPI_10Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.73810CD4Alexa 488FITC485525108R&D SystemsFAB8165G1:3000.5TONSIL-2.73910CD11cAlexa 555Cy355559058eBioscience41-9761-801:2000.5TONSIL-2.74010CD20Alexa 647Cy564069064eBioscience50-0202-801:10000.2TONSIL-2.74111DAPI_11Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.74211FibronectinAlexa 488FITC48552585Abcamab1989331:10000.5TONSIL-2.74311pAurAlexa 555Cy355559047Cell Signaling Technology13464 S1:2000.5TONSIL-2.74411STINGAlexa 647Cy564069086Abcamab1989521:1\'1:500.2TONSIL-2.74512DAPI_12Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.74612CD11bAlexa 488FITC48552594Abcamab2042711:3000.5TONSIL-2.74712CD3DAlexa 555Cy355559097Abcamab2085141:1\'1:500.5TONSIL-2.74812PD1Alexa 647Cy564069089Abcamab2018251:2000.5TONSIL-2.811DAPI_1Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.821A488 backgroundFITC4855250.5TONSIL-2.831A555 backgroundCy35555900.5TONSIL-2.841A647 backgroundCy56406900.5TONSIL-2.852DAPI_2Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.862A488 backgroundFITC4855250.2TONSIL-2.872A555 backgroundCy35555900.2TONSIL-2.882A647 backgroundCy56406900.2TONSIL-2.893DAPI_3Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.8103CD69Alexa 488FITC48552592Abcamab2029091:1000.5TONSIL-2.8113A555 backgroundCy35555900.5TONSIL-2.8123RORyTAlexa 647Cy5640690112EMD-MilliporeMABF811:500.5TONSIL-2.8134DAPI_4Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.8144CD69Alexa 488FITC48552592Abcamab2029091:1000.2TONSIL-2.8154A555 backgroundCy35555900.2TONSIL-2.8164RORyTAlexa 647Cy5640690112EMD-MilliporeMABF811:500.2TONSIL-2.8175DAPI_5Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.8185CD163Alexa 488FITC485525101Abcamab2182931:3000.5TONSIL-2.8195CD11cAlexa 555Cy355559058eBioscience41-9761-801:2000.5TONSIL-2.8205CD45Alexa 647Cy564069010BioLegend3040561:3000.5TONSIL-2.8216DAPI_6Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.8226IBAAlexa 488FITC48552582Abcamab1950311:5000.5TONSIL-2.8236CD11aAlexa 555Cy35555903BioLegend3012071:2000.5TONSIL-2.8246CD3Alexa 647Cy56406902BioLegend3004221:2000.5TONSIL-2.8257DAPI_7Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.8267TIM3Alexa 488FITC48552569Cell Signaling Technology54669 S1:3\'1:3\'1:30.5TONSIL-2.8277CD3DAlexa 555Cy355559097Abcamab2085141:2\'1:500.5TONSIL-2.8287PDL1Alexa 647Cy564069050Cell Signaling Technology15005 S1:5000.5TONSIL-2.8298DAPI_8Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.8308GATA3Alexa 488FITC48552535BD Biosiences 5601631:1000.5TONSIL-2.8318FoxP3Alexa 555Cy355559055eBioscience41-4777-821:1\'1:500.5TONSIL-2.8328Annexin VAlexa 647Cy564069037BioLegend6409111:1\'1:500.5TONSIL-2.8339DAPI_9Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.8349PCNAAlexa 488FITC48552572Cell Signaling Technology8580 S1:10000.2TONSIL-2.8359KeratinAlexa 555Cy355559056eBioscience41-9003-821:10000.1TONSIL-2.8369CD14Alexa 647Cy564069083Abcamab1961691:10000.5TONSIL-2.83710DAPI_10Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.83810CD38Alexa 488FITC4855259BioLegend3035111:1\'1:500.5TONSIL-2.83910CD68Alexa 555Cy35555901Cell Signaling Technology79594 S1:10000.5TONSIL-2.84010CD8aAlexa 647Cy5640690114eBioscience50-0008-821:2000.5TONSIL-2.84111DAPI_11Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.84211S100aAlexa 488FITC48552596Abcamab2073671:1\'1:500.1TONSIL-2.84311SQSTM1Alexa 555Cy355559093Abcamab2034301:1\'1:500.5TONSIL-2.84411Ki67Alexa 647Cy564069044Cell Signaling Technology12075 S1:3000.05TONSIL-2.84512DAPI_12Hoechst 33342DAPI395431119Cell Signaling Technology4082 S1:10000.03TONSIL-2.84612EGFRAlexa 488FITC48552570Cell Signaling Technology5616 S1:5000.5TONSIL-2.84712aSMAAlexa 555Cy355559090Abcamab2025091:10000.1TONSIL-2.84812CD20Alexa 647Cy564069064eBioscience50-0202-801:10000.2

Online-only Table 4Description of Features.FeatureDescriptionFieldIDSplit 6000 × 6000 field cells were segmented fromCellIdUnique cell identifier in a specific imageDAPI1Log-transformed mean intensity of pixels covered by segmentation for specified markerA488background1Log-transformed mean intensity of pixels covered by segmentation for specified markerA555background1Log-transformed mean intensity of pixels covered by segmentation for specified markerA647background1Log-transformed mean intensity of pixels covered by segmentation for specified markerDAPI2Log-transformed mean intensity of pixels covered by segmentation for specified markerA488background2Log-transformed mean intensity of pixels covered by segmentation for specified markerA555background2Log-transformed mean intensity of pixels covered by segmentation for specified markerA647background2Log-transformed mean intensity of pixels covered by segmentation for specified markerDAPI3Log-transformed mean intensity of pixels covered by segmentation for specified markerA488background3Log-transformed mean intensity of pixels covered by segmentation for specified markerLAG3Log-transformed mean intensity of pixels covered by segmentation for specified markerARL13BLog-transformed mean intensity of pixels covered by segmentation for specified markerDAPI4Log-transformed mean intensity of pixels covered by segmentation for specified markerKI67Log-transformed mean intensity of pixels covered by segmentation for specified markerKERATINLog-transformed mean intensity of pixels covered by segmentation for specified markerPD1Log-transformed mean intensity of pixels covered by segmentation for specified markerDAPI5Log-transformed mean intensity of pixels covered by segmentation for specified markerCD45RBLog-transformed mean intensity of pixels covered by segmentation for specified markerCD3DLog-transformed mean intensity of pixels covered by segmentation for specified markerPDL1Log-transformed mean intensity of pixels covered by segmentation for specified markerDAPI6Log-transformed mean intensity of pixels covered by segmentation for specified markerCD4Log-transformed mean intensity of pixels covered by segmentation for specified markerCD45Log-transformed mean intensity of pixels covered by segmentation for specified markerCD8ALog-transformed mean intensity of pixels covered by segmentation for specified markerDAPI7Log-transformed mean intensity of pixels covered by segmentation for specified markerCD163Log-transformed mean intensity of pixels covered by segmentation for specified markerCD68Log-transformed mean intensity of pixels covered by segmentation for specified markerCD14Log-transformed mean intensity of pixels covered by segmentation for specified markerDAPI8Log-transformed mean intensity of pixels covered by segmentation for specified markerCD11BLog-transformed mean intensity of pixels covered by segmentation for specified markerFOXP3Log-transformed mean intensity of pixels covered by segmentation for specified markerCD21Log-transformed mean intensity of pixels covered by segmentation for specified markerDAPI9Log-transformed mean intensity of pixels covered by segmentation for specified markerIBA1Log-transformed mean intensity of pixels covered by segmentation for specified markerASMALog-transformed mean intensity of pixels covered by segmentation for specified markerCD20Log-transformed mean intensity of pixels covered by segmentation for specified markerDAPI10Log-transformed mean intensity of pixels covered by segmentation for specified markerCD19Log-transformed mean intensity of pixels covered by segmentation for specified markerGFAPLog-transformed mean intensity of pixels covered by segmentation for specified markerGTUBULINLog-transformed mean intensity of pixels covered by segmentation for specified markerDAPI11Log-transformed mean intensity of pixels covered by segmentation for specified markerLAMINACLog-transformed mean intensity of pixels covered by segmentation for specified markerBANF1Log-transformed mean intensity of pixels covered by segmentation for specified markerLAMINBLog-transformed mean intensity of pixels covered by segmentation for specified markerAreaMatlab regionprops function: "Actual number of pixels in the region, returned as a scalar."EccentricityMatlab regionprops function: "Eccentricity of the ellipse that has the same second-moments as the region, returned as a scalar. The eccentricity is the ratio of the distance between the foci of the ellipse and its major axis length. The value is between 0 and 1. (0 and 1 are degenerate cases. An ellipse whose eccentricity is 0 is actually a circle, while an ellipse whose eccentricity is 1 is a line segment.)"SolidityMatlab regionprops function: "Proportion of the pixels in the convex hull that are also in the region, returned as a scalar. Computed as Area/ConvexArea."ExtentMatlab regionprops function: "Ratio of pixels in the region to pixels in the total bounding box, returned as a scalar. Computed as the Area divided by the area of the bounding box."EulerNumberMatlab regionprops function: "Number of objects in the region minus the number of holes in those objects, returned as a scalar. This property is supported only for 2-D label matrices. regionprops uses 8-connectivity to compute the Euler number measurement."PerimeterMatlab regionprops function: "Distance around the boundary of the region returned as a scalar. regionprops computes the perimeter by calculating the distance between each adjoining pair of pixels around the border of the region."MajorAxisLengthMatlab regionprops function: "Length (in pixels) of the major axis of the ellipse that has the same normalized second central moments as the region, returned as a scalar."MinorAxisLengthMatlab regionprops function: "Length (in pixels) of the minor axis of the ellipse that has the same normalized second central moments as the region, returned as a scalar."OrientationMatlab regionprops function: "Angle between the x-axis and the major axis of the ellipse that has the same second-moments as the region, returned as a scalar. The value is in degrees, ranging from −90 degrees to 90 degrees."X_positionX-position of the centroid calculated as the center of mass of the cell.Y_positionY-position of the centroid calculated as the center of mass of the cell.Percent_TouchingCellProfiler2.0 function: "Percent of the object's boundary pixels that touch neighbors, after the objects have been expanded to the specified distance."Number_NeighborsNumber of neighboring cells in a specified pixel extension.neighbor\_\*Cell identifier for all neighboring cells in a specified pixel extension.

Online-only Table 5Script Annotation.Script File NameProgramming LanguageDescriptionimagej_basic_ashlar.pyPythonScript used to run BaSiC and ASHLAR algorithms.run_ashlar_csv_batch.pyPythonScript used to run imagej_basic_ashlar.py for multiple samples in a batchome_to_individual_tiff.mMATLABScript used to extract, rename, and save the highest resolution TIFF images for each marker from the OME-TIFF filesplit_ome_tiff.mMATLABScript used to generate 6000 × 6000 pixel split regions and 250 × 250 pixel cropped regions from ome.tiff fileconvert_slices_from_Z\_to_X.ijmImageJScript used to convert image slices of cropped regions and training regions from Z to X for compatibility with ilastiksegment_from_ilastik_LUNG-1-LN.mMATLABScript used to generate segmentation masks from ilastik probability masks for LUNG-1-LNsegment_from_ilastik_LUNG-2-BR.mMATLABScript used to generate segmentation masks from ilastik probability masks for LUNG-2-BRsegment_from_ilastik_LUNG-3-PR.mMATLABScript used to generate segmentation masks from ilastik probability masks for LUNG-3-PRsegment_from_ilastik_TONSIL-1.mMATLABScript used to generate segmentation masks from ilastik probability masks for TONSIL-1combined_to_master_tableMATLABScript used to convert histoCAT tables from each split region into a master table for each sample
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All code used to process and generate the data in this study can be found alongside the dataset^[@CR29]^. A description of each script is provided in Online-only Table [5](#Tab7){ref-type="table"}. Source code for ASHLAR is available on GitHub (<https://github.com/jmuhlich/ashlar>). The newest histoCAT version can also be found GitHub (<https://github.com/BodenmillerGroup/histoCAT>).
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